Close Menu

NEW YORK (GenomeWeb) ― New Zealand startup Ubiquitome and custom oligo supplier Integrated DNA Technologies (IDT) announced a new partnership today to develop a hand-held Ebola assay.

The assay will be developed by IDT using the firm's PrimeTime qPCR Assay components. It will run on Ubiquitome's hand-held PCR platform, the Freedom4.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.